News

Doctors at the University of California - San Diego have discovered a new marker of one of America's deadliest cancers - ...
The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, ...
Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...
Baystreet.ca News Commentary – More and more young women are getting diagnosed with cancer than ever before, causing many to sound the alarm about reduced funding for prevention ...
USA News Group News Commentary – Cancer diagnoses are climbing fastest among younger women, sparking alarm that looming cuts ...
"We observed that the STRESS UP gene signature is linked to various critical stages of cancer development including: tumor ...
Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Company"), a leading clinical-stage company ...
Precancerous cells must adapt to and overcome cellular stress and inflammation in order to progress and form malignant tumors.
Relative to existing gene signatures, the STRESS signature better predicted not only whether cells would later develop into ...
Oncolytics Biotech reveals promising survival data for pelareorep, an innovative immunotherapy, showing significant benefits ...
Cancer immunotherapy has transformed the treatment landscape by helping the immune system recognize and attack tumors. At the ...
A specially engineered antibody capable of delivering RNA therapies to hard-to-reach, treatment-resistant tumors ...